Identification of anesthetic binding sites on human serum albumin using a novel etomidate photolabel.
We have synthesized a novel analog of the general anesthetic etomidate in which the ethoxy group has been replaced by an azide group, and which can be used as a photolabel to identify etomidate binding sites. This acyl azide analog is a potent general anesthetic in both rats and tadpoles and, as with etomidate, is stereoselective in its actions, with the R(+) enantiomer being significantly more potent than the S(-) enantiomer. Its effects on alpha1beta2gamma2s GABA(A) receptors expressed in HEK-293 cells are virtually indistinguishable from the parent compound etomidate, showing stereoselective potentiation of GABA-induced currents, as well as direct mimetic effects at higher concentrations. In addition, a point mutation (beta2 N265M), which is known to attenuate the potentiating actions of etomidate, also blocks the effects of the acyl azide analog. We have investigated the utility of the analog to identify etomidate binding sites by using it to photolabel human serum albumin, a protein that binds approximately 75% of etomidate in human plasma and which is thought to play a major role in its pharmacokinetics. Using HPLC/mass spectrometry we have identified two anesthetic binding sites on HSA. One site is the well-characterized drug binding site I, located in HSA subdomain IIA, and the second site is also an established drug binding site located in subdomain IIIB, which also binds propofol. The acyl azide etomidate may prove to be a useful new photolabel to identify anesthetic binding sites on the GABA(A) receptor or other putative targets.
Bright
Damian P
DP
Biophysics Section, Blackett Laboratory, Imperial College, South Kensington, London SW7 2AZ, United Kingdom.
Adham
Sara D
SD
Lemaire
Lucienne C J M
LC
Benavides
Rodrigo
R
Gruss
Marco
M
Taylor
Graham W
GW
Smith
Edward H
EH
Franks
Nicholas P
NP
D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D001386:Azides / Q000494:pharmacology; D001665:Binding Sites; D004305:Dose-Response Relationship, Drug; D005045:Etomidate / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008956:Models, Chemical; D011485:Protein Binding; D011896:Rana temporaria; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000737:chemistry*; D013237:Stereoisomerism
D000777:Anesthetics; D001386:Azides; D012709:Serum Albumin; C519839:acyl azide etomidate; D005045:Etomidate